| Q.8 | On 12 July 2022, the Drugs Controller General of India (DCGI) granted market authorisation to Serum Institute of India (SII) to manufacture India’s first indigenously developed vaccine against ______. | |
| Ans | 1. endometrial cancer | |
| 2. ovarian cancer | ||
| 3. cervical cancer | ||
| 4. breast cancer |
Correct Ans: 3